Compton Capital Management Inc Abb Vie Inc. Transaction History

Compton Capital Management Inc

$4.32 Billion
Q2 2023

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$144.61 - $166.54 $1.89 Million - $2.18 Million	-13,100 Reduced 72.0%	5,094 $811,000
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $221,296 - $265,392	-1,600 Reduced 8.08%	18,194 $2.94 Million
Q3 2022 Nov 08, 2022	SELL	$134.21 - $153.93 $185,344 - $212,577	-1,381 Reduced 6.52%	19,794 $2.66 Million
Q2 2022 Aug 11, 2022	SELL	$137.62 - $174.96 $1.88 Million - $2.39 Million	-13,638 Reduced 39.18%	21,175 $3.24 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $83,147 - $103,162	-630 Reduced 1.78%	34,813 $5.64 Million
Q4 2021 Feb 07, 2022	SELL	$107.43 - $135.93 $105,818 - $133,891	-985 Reduced 2.7%	35,443 $4.8 Million
Q3 2021 Nov 10, 2021	BUY	$106.4 - $120.78 $63,414 - $71,984	596 Added 1.66%	36,428 $3.93 Million
Q2 2021 Aug 11, 2021	SELL	$105.21 - $117.21 $21,042 - $23,442	-200 Reduced 0.56%	35,832 $4.04 Million
Q1 2021 May 04, 2021	SELL	$102.3 - $112.62 $51,150 - $56,310	-500 Reduced 1.37%	36,032 $3.9 Million
Q4 2020 Feb 08, 2021	BUY	$80.49 - $108.67 $60,930 - $82,263	757 Added 2.12%	36,532 $3.91 Million
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $23,539 - $27,627	-274 Reduced 0.76%	35,775 $3.13 Million
Q2 2020 Aug 12, 2020	BUY	$73.37 - $98.18 $121,280 - $162,291	1,653 Added 4.81%	36,049 $3.54 Million
Q1 2020 May 06, 2020	BUY	$64.5 - $97.79 $83,527 - $126,638	1,295 Added 3.91%	34,396 $2.62 Million
Q4 2019 Feb 10, 2020	SELL	$72.13 - $90.25 $140,653 - $175,987	-1,950 Reduced 5.56%	33,101 $2.93 Million
Q3 2019 Nov 07, 2019	BUY	$62.98 - $75.72 $180,122 - $216,559	2,860 Added 8.88%	35,051 $2.65 Million
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $434,277 - $555,107	6,610 Added 25.84%	32,191 $2.34 Million
Q1 2019 May 14, 2019	SELL	$77.14 - $90.79 $15,428 - $18,158	-200 Reduced 0.78%	25,581 $2.06 Million
Q4 2018 Feb 13, 2019	SELL	$77.85 - $96.01 $180,612 - $222,743	-2,320 Reduced 8.26%	25,781 $2.38 Million
Q3 2018 Nov 06, 2018	BUY	$88.91 - $98.84 $33,341 - $37,065	375 Added 1.35%	28,101 $2.66 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $15,442 - $18,271	172 Added 0.62%	27,726 $2.57 Million
Q1 2018 May 11, 2018	BUY	$92.01 - $123.21 $41,864 - $56,060	455 Added 1.68%	27,554 $2.61 Million
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $8,508 - $9,329	95 Added 0.35%	27,099 $2.62 Million
Q3 2017 Nov 14, 2017	SELL	$69.85 - $89.22 $67,125 - $85,740	-961 Reduced 3.44%	27,004 $2.4 Million
Q2 2017 Aug 14, 2017	BUY	N/A	27,965	27,965 $2.03 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $317B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Compton Capital Management Inc , based on Form 13F filings with the SEC.

News

Stay updated on Compton Capital Management Inc with notifications on news.

Account